Dishman Pharmaceuticals and Chemicals' subsidiary Carbogen Amcis AG has acquired Creapharm Parenterals. In an interview to CNBC-TV18, VVS Murthy, chief financial officer of Dishman Pharma says, it is a small R&D formulation development company. The acquisition, he says, is funded trough internal accruals.
first published: Jan 19, 2012 02:44 pm
A collection of the most-viewed Moneycontrol videos.
Trump Claims Iran Will Never Shut Hormuz Again, Big Statement Raises Global Questions
AMIT SHAH FULL SPEECH: Amit Shah Addresses Lok Sabha on Reservation, Delimitation & Representation
Live: Broader markets outperform this week; Metal, realty top sectoral plays | Closing Bell
Trump Signals Major Breakthrough In Iran Deal, May Visit Islamabad Soon
